Human Immunodeficiency Virus (HIV) Infections (AIDS) Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

Human Immunodeficiency Virus (HIV) Infections (AIDS)

27 Aug 2026
ViiV Healthcare’s Tivicay PD gains FDA approval for paediatric HIV therapy

By Salong Debbarma

The US Food and Drug Administration (FDA) has approved ViiV Healthcare’s Tivicay PD (dolutegravir), for use with other antiretroviral agents in paediatric patients with human immunodeficiency virus type 1 (HIV-1) who weigh at least 2kg.
16 Mar 2021
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Gilead, Merck agreement to develop HIV treatments lenacapavir and islatravir

By PBR Staff Writer

California-based biopharmaceutical company Gilead Sciences, Inc. and New Jersey-based Merck have announced their agreement to develop and commercialise the long-acting HIV treatments lenacapavir and islatravir.